Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
977.8 INR | +3.36% | +5.13% | +4.99% |
06:13am | Jefferies Forecasts Strong Fiscal Q1 for Indian Pharmaceuticals | MT |
Jul. 08 | Piramal Enterprises Limited Approves Final Dividend for the Financial Year Ended 31St March, 2024 | CI |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The company appears to be poorly valued given its net asset value.
Weaknesses
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Consumer Lending
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.99% | 2.55B | - | ||
-3.67% | 52.24B | C+ | ||
-4.52% | 30.56B | C+ | ||
+47.78% | 27.02B | - | - | |
+39.42% | 26.64B | B | ||
+35.61% | 20.37B | B | ||
+11.91% | 14.21B | C+ | ||
+37.26% | 12.97B | B- | ||
+24.27% | 8.82B | C | ||
+166.22% | 8.04B | - | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- PEL Stock
- PEL Stock
- Ratings Piramal Enterprises Limited